Forensics

AMRZ — quarterly fundamentals

CIK 2035989 · clean
Figures as originally filed. Where a value was later revised, the restatement is shown beside it — a period filed once and never revised shows no arrow, which is a different statement from having no restatement data.
PeriodEnds RevenueNet income Diluted EPSEBITDAOp. cash flow
2026Q2 restated 2026-06-30 3594000000 → 3586000000 460000000 → 467000000 0.83 → 0.84 890000000 → 879000000 381000000 → 372000000
2026Q1 restated 2025-03-31 2081000000 → 2089000000 -87000000 → -94000000 -0.16 → -0.17 165000000 → 176000000 -856000000 → -847000000
2025 FY 2023-12-31 11677000000 956000000 1.73 2577000000 2036000000
Long US-equity 13F disclosures only · up to 45-day reporting lag · sells = reduce/avoid, not short. JSON: /api/signals · /api/funds · /api/status